The regulation of the expression of interstitial collagenase and tissue inhibitor of metalloproteinases (TIMP) was examined in response to both retinoid compounds and glucocorticoids. Effective retinoids induced a dose-dependent, specific increase in the production of TIMP of -two-to threefold by monolayer cultures of human fibroblasts derived from various tissues, while simultaneously causing a decrease in collagenase secretion of similar magnitude. These effects were apparent by 8-12 h in culture and disappeared within 24 h after the withdrawal of retinoid compounds. The retinoid effect on TIMP production was mediated via an increased biosynthesis of new inhibitor protein. Similarly, increased steady state levels of TIMP messenger RNA (mRNA) accompanied by decreased quantities of collagenase mRNA were demonstrated, suggesting transcriptional control of the retinoid action. The data suggest that retinoids co-regulate the expression of collagenase and TIMP, and do so in an inverse manner.
Introduction
The degradation of interstitial collagens is dependent upon the activity of collagenase, the enzyme that catalyzes the initial cleavage of the native collagen molecule (1) . Control over collagenase activity in vivo is likely to be a complex biologic process involving factors such as the regulation of procollagenase biosynthesis, enzyme secretion from the cell, zymogen activation, and inhibition of active collagenase by proteinase inhibitors. Human skin fibroblasts in monolayer culture produce a collagenase inhibitor (tissue inhibitor of metalloproteinases [TIMP] )' that has been extensively studied and characterized (2, 3) , and that may serve to regulate collagenase activity in the extracellular space.
Human fibroblast TIMP is a 28,500-D glycoprotein (2) that inhibits a variety of metalloproteinases of connective tissue origin, including collagenase, gelatinase, and proteoglycanase (4) . The purification of human skin fibroblast TIMP to homogeneity and subsequent development of specific antibody (2) led to the identification of this protein as a secretory product of human fibroblasts of diverse tissue origin, smooth muscle cells, osteoblasts (3) , and human mononuclear phagocytes, including alveolar macrophages (5) . Human skin fibroblast TIMP was also identified in several body fluids, including plasma, serum, and amniotic fluid (2) , and as a constituent of the a-granule of human platelets (6) . The primary structure of human TIMP has recently been determined both by the isolation of the corresponding complementary DNA (cDNA) clone and nucleotide sequencing (7, 8) , as well as by primary amino acid sequence analysis (8) . This inhibitor molecule is capable of inhibiting active collagenase on a 1:1 molar stoichiometric basis (9) via the formation of a very high affinity (inhibition constant < l0-9 M), though noncovalent, enzyme-inhibitor complex (10, 1) . The ubiquity of human TIMP and its ability to regulate the activity of several degradative enzymes suggests a major role for this molecule in modulating the turnover of human connective tissues.
A number of physiologic and pharmacologic agents have been identified that can regulate the production of collagenase by fibroblasts (12) (13) (14) (15) (16) (17) (18) (19) , but only phorbol esters and interleukin 1 (IL-1) have also been studied extensively with regard to their action on TIMP biosynthesis. Phorbol esters have been demonstrated to induce a dose-dependent increase in the production of both collagenase and TIMP by human fibroblasts (20, 21) . Similarly, IL-1 has been shown to stimulate the synthesis of collagenase (13, 16, 18, 20) and of TIMP (20) by a variety of human fibroblasts and synovial cells. These results have suggested to some investigators that collagenase and TIMP expression are generally regulated in the same direction, perhaps even in a coordinate manner.
Since both the retinoid compounds (14, 22, 23) and glucocorticoids (12, 24, 25) have been shown to specifically diminish collagenase production in fibroblasts, we examined the effect of such agent upon the expression of TIMP. Our data indicate that effective retinoids induce a dose-dependent, specific increase in TIMP synthesis that is generally two-to threefold above basal secretory rates, while simultaneously reducing collagenase secretion by a similar magnitude. The retinoid effect on TIMP and collagenase production is apparent by 8-12 h in culture, and disappears within 24 (27) Effect ofdifferent retinoids. To study the ability ofdifferent retinoid compounds to modulate the production of TIMP, replicate secondary cultures of human skin fibroblasts were exposed to 10-5 and 10-6 M concentrations ofall-trans-retinoic acid, retinal, retinol, 1 3-cis-retinoic acid, etretin, and etretinate in serum-containing medium for 48 h. Samples ofconditioned media were then analyzed for immunoreactive TIMP by ELISA.
Assay procedures
Collagenase and TIMP levels in conditioned media were quantitated immunologically by ELISA, each assay having a sensitivity of -5 ng (3, 27) . Each ELISA measures the total amount of that particular protein, whether it is present in a free or bound state. Furthermore, the same samples of conditioned media were generally assayed for both collagenase and TIMP.
To examine any possible effects upon total new protein synthesis by all-trans-retinoic acid or dexamethasone, replicate cultures of human skin fibroblasts were initiated in 35-mm-diameter cluster wells. After exposure to either retinoid, steroid, or the appropriate solvent control, the cells were washed three times with HBSS and then incubated for 8 h in otherwise identical culture medium containing 10 MCi/ml of [3H]leucine. The conditioned media were collected, after which the cell layer was scraped with a rubber policeman into a l-ml volume of buffer (phosphate-buffered saline, pH 7.5), and then subjected to sonication. New protein synthesis was determined as the amount of [3Hlleucine incorporated into trichloroacetic acid-insoluble material in the medium and cells. Conditioned media were simultaneously assayed for collagenase and TIMP by ELISA.
DNA content was determined by lysing the cell layer with 0.3 M NaOH and assaying for DNA by established methods (28) .
Metabolic labeling and immunoprecipitation of TIMP. Metabolic labeling studies designed to immunoprecipitate newly synthesized TIMP were conducted by exposing replicate cultures of fibroblasts in 35-mm-diameter cluster wells to serum-containing medium with and without 1 0' and 10-6 M all-trans-retinoic acid for 24 h. After extensive washing of the cell layer, the cultures were incubated for an additional 24 h in leucine-free, serum-free medium containing 10-' and 10-6 M all-trans-retinoic acid or an appropriate concentration of Me2SO, and 30 MCi/ml of [3Hlleucine. Aliquots of 400 gl of pulsed medium were then immunoprecipitated using TIMP-specific antibody (2, 3) and subjected to sodium dodecyl sulfate (SDS)-gel electrophoresis (29) and autoradiography (30) as described previously (21) .
Isolation of RNA and Northern blot analysis. Human skin fibroblasts in 850-cm2 roller bottles were incubated with 100 ml of culture medium containing all-trans-retinoic acid (l0-5 and 10-6 M), dexamethasone (10-7 M), or the appropriate solvent control. Four roller bottles were employed for each condition, and after 24 or 48 h of incubation total cytoplasmic RNA was isolated according to established procedures (31). The total RNA was then fractionated on a 1.2% agarose gel containing 2.2 M formaldehyde (32) , transferred to nitrocellulose filters, and hybridized to a nick-translated collagenase cDNA probe as previously described by Goldberg et al. (33) . Hybridization to a nick-translated cDNA TIMP probe was accomplished by incubating the nitrocellulose filter in 10-15 ml of 0.27 M sodium phosphate (pH 7.2) containing 1 mM EDTA, 1% BSA (wt/vol) and 7% SDS (wt/vol) at 650C for 16 h. The buffer was then replaced with an equal volume of identical buffer containing the 32P-labeled cDNA TIMP probe titrated to 10-6 cpm/ml, and the filter was exposed to this mixture at 65"C for 16 -24 h. The filter was then washed twice with 500 ml of buffer at 650C for 15 min. Autoradiography was performed at -70'C using Kodak XAR-5 X-Omat AR film (30) .
Results
The effect of various concentrations of all-trans-retinoic acid on the production of TIMP and collagenase by human skin fibroblasts is shown in Fig. 1 . Concentrations of all-trans-retinoic acid ranging from 10-8 to 10-5 M in serum-containing culture medium caused a dose-dependent increase in the secretion of immunoreactive TIMP (Fig. 1 A) , reaching levels generally two-to threefold in excess of basal production rates.
Production of inhibitor was 50% of maximal at -5 X 1O-' M retinoid and maximal at 1 X 10-5 M. However, when collagenase production was examined, a biphasic response was observed. Collagenase secretion was sharply diminished in the presence of 10-and 10-6 M all-trans-retinoic acid, whereas lower retinoid concentrations (10-7-1-0 M) mildly stimulated the release of this proteinase (Fig. 1 B) . The decrease in collagenase secretion, to values less than half of basal production rates, was maximal at 1 X 10-5 M retinoid and 50% of maximal at -8 X l0-' M, similar to the corresponding concentrations that modulated TIMP expression. When these experiments were performed in culture medium lacking fetal bovine serum, similar results were obtained (data not shown).
To determine whether this response to retinoic acid was a generalized biologic phenomenon, several lines of human fibroblasts derived from a variety of tissues were next examined. All strains tested, including four lines of adult human skin fibroblasts, two lines of fetal human skin fibroblasts, and one line each of adult lung, fetal lung, and gingival fibroblasts, manifested a significant decrease in collagenase production and a concomitant increase in TIMP secretion when exposed to 10-' or 10-6 M all-trans-retinoic acid ( Table I ). The magnitude of the reduction in -collagenase secretion produced by the retinoid ranged from 49-74% of baseline values. The increase in TIMP production ranged from 29 to 230% of basal rates, averaging 83%. In a single experiment, one line of adult human skin fibroblasts manifested a 618% increase in inhibitor secretion (CRL 1454; data not shown).
To examine the specificity of the regulatory effects of retinoic acid on TIMP and collagenase production, total new protein synthesis was determined by pulsing culture medium with M all-trans-retinoic acid and control cellular lysates were 28,790, 38,937, and 37,843, respectively. The counts per minute precipitated in the l0-5 and 10-6 M all-trans-retinoic acid and control conditioned media samples were 5,664, 5,703, and 4,869, respectively. Thus, total protein synthesis was not substantially altered in either cellular lysates or conditioned media by the presence of all-trans-retinoic acid. Total DNA content, determined in this and all other experiments, was also unaffected by retinoic acid conditioning (data not shown).
The time course that characterizes the regulatory action of all-trans-retinoic acid on TIMP and collagenase production was next examined. As shown in Fig. 2 (Fig. 2 B) . An inhibitory effect of all-trans-retinoic acid on collagenase secretion was apparent after 12 h in culture, and became maximal by 24 h.
Experiments were next performed to examine the release of human skin fibroblasts from the action of all-trans-retinoic acid. Cells were incubated in the presence of 10-5 M all-transretinoic acid for 24 h, after which the culture medium was replaced with fresh, otherwise identical medium lacking retinoid and aliquots removed at regular intervals thereafter. As shown in Fig. 3 A, fibroblasts ceased to produce elevated levels of TIMP -24 h after the removal of retinoid from culture medium. Similarly, when conditioned media samples were assayed immunologically for collagenase (Fig. 3 B) , at 4 and 8 h after the removal of retinoid, enzyme production continued at a diminished level as compared with control cells. However, by 24 h after removal, the cells preconditioned with retinoic acid were secreting collagenase at the same rate as the untreated cells. Thus, the effects of all-trans-retinoic acid on the production of TIMP and collagenase were essentially indistinguishable with respect to parameters of time of onset, time of maximal effect, and duration of action.
To examine the spectrum of vitamin A derivatives that were capable of stimulating TIMP production, replicate cultures of human skin fibroblasts were exposed to 10-' and 10-6 M concentrations of all-trans-retinoic acid, 13-cis-retinoic acid, etretinate, etretin, retinal, or retinol (Table II) . Condi To gain insight into the mechanisms whereby retinoic acid alters the pattern of TIMP and collagenase production by human fibroblasts, metabolic labeling and immunoprecipitation studies as well as Northern hybridization analyses were performed. Human skin fibroblasts, either untreated or retinoid-conditioned, were exposed to [3H]leucine, and the labeled medium proteins were subjected to immunoprecipitation using TIMP-specific antibody (2, 5) . As shown in Fig. 4 , the fibroblasts exposed to 10-5 or 10-6 M retinoic acid synthesized greater quantities of TIMP than untreated cells. Furthermore, this increase in the biosynthesis of TIMP paralleled the increased amounts of inhibitor protein secreted into culture medium as measured by ELISA. Assessment of TIMP and collagenase mRNA levels in response to retinoid treatment was accomplished by the isolation of total RNA and Northern blot analysis. As shown in Fig. 5, fibroblasts We now focused our attention on whether the glucocorticoid compounds, agents known to suppress collagenase production (12, 24, 25) , can also regulate TIMP expression. Human skin fibroblasts in monolayer culture were incubated with concentrations of dexamethasone ranging from 10" to 10-7 M under serum-free conditions for 48 h. Conditioned media were then collected and assayed for both collagenase and TIMP by ELISA. As shown in Fig. 6 , dexamethasone induced a dose-dependent decrease in immunoreactive collagenase, but failed to alter appreciably the amounts of secreted TIMP. Such results were also observed using three additional human skin fibroblast cell lines, subjected to either dexamethasone or hydrocortisone (data not shown). Experiments per-(I0-5M) 
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The TIMP cDNA hybridized to mRNA of 0.9 kilobase (kb) in size (8) , whereas the collagenase cDNA hybridized to mRNA of 2.5 kb (33) . ELISA measurements of the retinoic acid vs. control media showed 9.68 Mg TIMP/106 cells vs. formed in the presence of serum gave less consistent collagenase effects and required higher concentrations of the glucocorticoids, presumably due to steroid binding to serum proteins (data not shown).
To analyze these glucocorticoid effects further, total RNA was harvested from dexamethasone-treated and control fibroblasts and subjected to Northern hybridization using TIMP and collagenase cDNA probes. As shown in Fig. 7 
Discussion
The data presented in this report clearly indicate that the regulation of fibroblast interstitial collagenase and TIMP, proteins integrally involved in collagen turnover, can occur by a variety of mechanisms. The retinoid compounds, a group of naturally occurring and synthetic vitamin A derivatives, appear to induce a specific increase in the biosynthesis of TIMP, while concomitantly causing a selective reduction in collagenase production. Our results, therefore, both confirm and extend the earlier preliminary observations of Bauer et al. (23) and Brinckerhoffet al. (34) . These effects, by and large, are present only at higher retinoid concentrations (l0-' and 10-6 M), but are apparent in human fibroblasts of diverse tissue origin, including skin, lung, and gingiva, whether the cells are adult or fetal in nature. Modulation of collagenase and TIMP expression by retinoids is therefore very different from the regulatory effects exerted upon these proteins that have been previously described for phorbol esters (20, 21) and the cytokine IL-1 (20 ety of mechanisms. Expression appears to be co-regulated in an inverse manner by retinoids and independently modulated by dexamethasone, but elucidation of the exact intracellular mechanisms underlying the effects of such agents will require additional studies directed at the gene level. The ability of glucocorticoid compounds such as hydrocortisone and dexamethasone to suppress interstitial collagenase production has been well established by a variety of previous investigations (12, 24, 25) . This phenomenon has been a consistent finding in studies of human fibroblasts (25) , human skin explants (12) , and rat uterus explants (12) . In the present report, we have also documented the capacity of dexamethasone to induce a marked diminution in collagenase production from human skin fibroblasts, as evidenced by both decreased secretion of immunoreactive material into culture medium and by suppressed steady state levels of enzyme-specific mRNA (Figs. 6 and 7) . However, even at concentrations of dexamethasone as high as 10-0 M, sufficient to suppress collagenase production by -70%, there was no effect observed on either immunoreactive TIMP protein secreted into culture medium or in steady state levels of TIMP mRNA by Northern hybridization. Higher concentrations of dexamethasone (10-6 M) in serum-free medium reduced the production of TIMP, but always by an amount essentially equal to the level of suppression observed in total new protein synthesis as measured by the incorporation of [3H]leucine into trichloroacetic acidprecipitable protein, presumably reflecting cellular toxicity caused by this high concentration of the glucocorticoid (data not shown). At this point, our data differ from results obtained from synovial cultures (35) . In these cultures, a stimulation in the expression of TIMP occurs upon exposure to glucocorticoids. It may well be that synovial cells and fibroblasts are regulated by the retinoids in a different manner. On the other hand, it may be that the availability to us of immunologic and cDNA probes to examine the production of TIMP and collagenase individually has provided more accurate measurements than were possible in previous investigations that were forced to rely solely upon determinations of functional activity.
The data presented in this report provide some insights into the mechanisms whereby retinoid compounds exert their action on collagenase and TIMP expression by human fibroblasts. Examination of immunoreactive material secreted into culture medium indicate a detectable diminution in the rate of collagenase production and a measurable stimulation of inhibitor release within 8-12 h after the addition of retinoid (Fig. 2) . The augmentation in TIMP expression is paralleled by an equivalent increase in the biosynthesis of new inhibitor protein, as demonstrated by pulse labeling of the cells and immunoprecipitation usign TIMP-specific antibody (Fig. 4) . Furthermore, these events are also correlated with the presence of elevated steady state levels of TIMP mRNA as measured in Northern blot analysis using a specific cDNA probe (Fig. 5) . Previous work has demonstrated that all-trans-retinoic acid diminishes collagenase production via a transcriptional mechanism, decreasing collagenase mRNA steady state levels without affecting mRNA half-life (36) . Our findings confirm this work in part, in that the decrease in collagenase released from retinoic acid-exposed cells was mirrored by substantially reduced levels of collagenase mRNA isolated from such fibroblasts, and also suggest that the vitamin A derivatives exert their effects upon TIMP expression at a transcriptional level of regulation. In any event, the results presented in Fig. 3 also clearly indicate that the effect of retinoid compounds upon such cells is reversible. Within -24 h after the removal of retinoic acid from culture medium, basal levels of both collagenase and TIMP secretion from the cells are resumed.
The results of our experiments may also have implications regarding the in vivo effects of retinoid and glucocorticoid compounds on collagen metabolism and connective tissue turnover. In the case of the glucocorticoids, there is considerable evidence that such compounds markedly diminish collagen synthesis (37) , also decrease collagenase production (12, 24, 25) , and from the present data appear to have no effect on the elaboration of TIMP. Although this modulation of collagen and collagenase expression would be expected to result in opposing influences upon collagen turnover, the effect of glucocorticoids on the structural protein's biosynthesis is likely to be the dominant factor, as such agents clearly reduce the mass of connective tissues when employed pharmacologically (38) . Similarly, the vitamin A derivatives have been reported to decrease collagen synthesis in vitro (39) , and also decrease the production of interstitial collagenase (14, 22, 36 (23) . Our studies indicate that the naturally occurring retinoic acids, all-trans-retinoic and 13-cis-retinoic acids, are quite potent in stimulating TIMP production, whereas the synthetic compounds etretinate and its metabolite etretin have little or no significant effect. However, these effects are produced only at the higher levels of retinoids employed in this study, concentrations of at least 10-6 M. In fact, our data provide evidence that collagenase modulation may be biphasic in nature, with some stimulation of enzyme production occurring at lower retinoid concentrations (Fig. 1) . Whereas the regulation of collagen turnover is undoubtedly a complex biologic process involving not only the production of collagenase and TIMP, but also factors such as procollagenase activation, extracellular compartmentalization, and the formation and removal of enzyme-inhibitor complexes, our data do suggest that there are a variety of mechanisms whereby regulatory agents can modulate the expression of these fibroblast proteins. Further complexity is added by the knowledge that proteins identical to fibroblast interstitial collagenase and TIMP are elaborated by other cell types such as mononuclear phagocytes (5), which likely participate in mediating collagen turnover both in normal connective tissue metabolism and in disease states. Future investigations will therefore necessarily focus upon aspects of the regulation and interplay of such resident and inflammatory cells in modulating collagen turnover.
